peptic ulcer disease and H. pylori

in review 4 min read Updated 2026-10-28
peptic ulcer disease and H. pylori

Most ulcers are H. pylori or NSAID/ASA. Test with a non-serological test (urea breath test, stool antigen, biopsy) after a 2-week PPI and 4-week antibiotic/bismuth washout. First-line: bismuth quadruple therapy (PBMT) × 14 days — recommended by both Canadian and US guidelines and unaffected by clarithromycin resistance. Avoid clarithromycin or levofloxacin unless susceptibility is known. Test of cure for everyone, ≥4 weeks after treatment. Ulcer on NSAID/antiplatelet that must continue → PPI.

who to test

Testing commits to treating — only test if a positive result would be treated.

  • peptic ulcer, active or past (including bleeding ulcer — repeat a negative test from the acute bleed later)
  • gastric MALT lymphoma
  • uninvestigated dyspepsia <60 without alarm features (test-and-treat instead of endoscopy)
  • long-term NSAIDs, or starting long-term low-dose ASA
  • unexplained iron deficiency anaemia (iron deficiency); immune thrombocytopenia
  • gastric cancer prevention: first-degree relative with gastric cancer, prior early gastric cancer resection, gastric premalignant conditions (atrophic gastritis and gastric intestinal metaplasia), immigrants from high-incidence regions

ACG 2024 also tests adult household members of infected patients — not adopted in Canadian guidance.

tests

testusepitfalls
urea breath testdiagnosis and test of curefalse negative on PPI (stop 2 weeks), antibiotics or bismuth (stop 4 weeks)
stool antigendiagnosis and test of curesame washouts
biopsy (histology, rapid urease)at endoscopyfalse negative during acute bleed and on PPI
serologynot for test-and-treatstays positive for years after cure → can’t show active infection or cure

H2RAs and antacids don’t affect the tests — use them for symptoms during the washout.

eradication

All regimens 14 days (longer duration → higher eradication). PPI dosed 30–60 min before meals.

regimencomponentsrole
PBMT (bismuth quadruple)PPI BID + bismuth subsalicylate or subcitrate QID + metronidazole 500 mg TID–QID + tetracycline 500 mg QIDfirst-line (Toronto, ACG); also first rescue if not used before
PAMC (concomitant)PPI + amoxicillin 1 g + metronidazole 500 mg + clarithromycin 500 mg, all BIDToronto first-line option; ACG avoids without known clarithromycin susceptibility
PPI triple (PAC)PPI + amoxicillin + clarithromycinonly where clarithromycin resistance <15% or local eradication >85% — rarely true in Canada
levofloxacin triple (PAL)PPI + amoxicillin + levofloxacinrescue only (not first-line)
rifabutin triplePPI + amoxicillin + rifabutinACG first-line option and rescue after PBMT; Toronto restricts to after ≥3 failures
vonoprazan + amoxicillinpotassium-competitive acid blocker dualACG first-line option; vonoprazan availability in Canada limited
  • Doxycycline is not a substitute for tetracycline.
  • Bismuth subsalicylate → avoid with salicylate allergy; black stool and tongue are expected.
  • Metronidazole: no alcohol; resistance is overcome by full-dose, 14-day PBMT.
  • Don’t reuse clarithromycin or levofloxacin after a regimen containing them fails.
  • Penicillin allergy → allergy assessment (most labels are wrong); PBMT contains no penicillin.
  • Probiotics don’t improve eradication.

Rescue: PBMT if not used → levofloxacin-based (if susceptible) or rifabutin-based. Susceptibility testing when the choice is unclear.

test of cure

Everyone, ≥4 weeks after therapy, with urea breath test, stool antigen or biopsy; PPI off for 2 weeks first. Not serology.

NSAIDs, ASA and antithrombotics

  • Ulcer while on NSAID → stop the NSAID; if it must continue → COX-2 inhibitor + PPI (each alone still carries meaningful rebleed risk after a bleed).
  • Low-dose ASA for secondary prevention → continue with a PPI; test and treat H. pylori.
  • DAPT, or antiplatelet + anticoagulant, after an ulcer bleed → long-term PPI. Clopidogrel → pantoprazole (antiplatelets).
  • Acute bleeding ulcer management → upper GI bleeding.

ulcer follow-up

  • Gastric ulcer → biopsy at index endoscopy; repeat endoscopy to confirm healing if malignancy wasn’t excluded.
  • PPI once daily for a duration set by the cause; long-term only if NSAID/antithrombotic exposure continues.
  • Refractory or recurrent ulcers despite eradication and no NSAIDs → hidden NSAID/ASA use, failed eradication, malignancy, Crohn’s, or Zollinger–Ellison syndrome (multiple or post-bulbar ulcers, diarrhoea, thick folds) → fasting gastrin off PPI.

Prepared 2026-10-28. Not yet verified — check every number against the sources.

Key references

+1 more source

Suggest a correction peptic ulcer disease and H. pylori